Fonte: The Lancet HIV. Unidade: FMRP
Assuntos: ANTI-HIV, ANTICORPOS, MÉTODO DUPLO-CEGO, INFECÇÕES POR HIV, VACINAS, GRAVIDEZ, STREPTOCOCCUS PNEUMONIAE
ABNT
WEINBERG, Adriana et al. Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial. The Lancet HIV, v. 8, n. 7, p. e408–19, 2021Tradução . . Disponível em: https://doi.org/10.1016/S2352-3018(20)30339-8. Acesso em: 20 ago. 2024.APA
Weinberg, A., Muresan, P., Laimon, L., Pelton, S. I., Goldblatt, D., Canniff, J., et al. (2021). Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial. The Lancet HIV, 8( 7), e408–19. doi:10.1016/S2352-3018(20)30339-8NLM
Weinberg A, Muresan P, Laimon L, Pelton SI, Goldblatt D, Canniff J, Zimmer B, Bone F, Duarte G, Mussi-Pinhata MM. Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial [Internet]. The Lancet HIV. 2021 ; 8( 7): e408–19.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1016/S2352-3018(20)30339-8Vancouver
Weinberg A, Muresan P, Laimon L, Pelton SI, Goldblatt D, Canniff J, Zimmer B, Bone F, Duarte G, Mussi-Pinhata MM. Safety, immunogenicity, and transplacental antibody transport of conjugated and polysaccharide pneumococcal vaccines administered to pregnant women with HIV: a multicentre randomised controlled trial [Internet]. The Lancet HIV. 2021 ; 8( 7): e408–19.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1016/S2352-3018(20)30339-8